NewGenIvf and A SPAC I Announce Closing of Business Combination PR Newswire NEW YORK, April 3, 2024 NewGenIvf's shares and warrants are expected to begin trading on the Nasdaq Capital Market...
NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination PR Newswire NEW YORK, March 5, 2024 Combined company to be named NewGenIvf Group LimitedNEW YORK, March 5, 2024...
NewGenIvf, a full-service fertility services provider in Asia, Announces Plans to List on Nasdaq Through Merger with A SPAC I Acquisition Corp. PR Newswire NEW YORK, Feb. 16, 2023 NEW YORK, Feb...
New Avenues to Market - Research Report on Isis Pharmaceuticals, Inc., Avon Products, Inc., Elizabeth Arden, Inc., Boyd Gaming Corporation and Ameristar Casinos, Inc. PR Newswire NEW YORK...
LAS VEGAS, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Pinnacle Entertainment, Inc. (NYSE:PNK) and Ameristar Casinos, Inc. (Nasdaq:ASCA) announced today that on February 11, 2013 they received a request...
WeissLaw LLP, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other...
Levi & Korsinsky notifies investors of Ameristar Casinos, Inc. (“Ameristar” or the “Company”) (NasdaqGS: ASCA) of claims of breaches of fiduciary duty and other violations of...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Ameristar Casinos, Inc. (“Ameristar” or the...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ameristar Casinos, Inc. (“Ameristar” or the “Company”...
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Ameristar Casinos, Inc. in Connection with the Sale of the Company to...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales